Showing results (31-40 of 110) with videos related to
Sort By:
Pageof 11
Neuroscience Letters|May 22, 2012
Inhibition of lipid peroxidation and protein oxidation by endogenous and exogenous antioxidants in rat brain microsomes in vitroCesare Mancuso, Eugenio Barone, Pina Guido, et al.Journal of Neurochemistry|October 19, 2011
Biliverdin reductase-A: a novel drug target for atorvastatin in a dog pre-clinical model of Alzheimer diseaseEugenio Barone, Cesare Mancuso, Fabio Di Domenico, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 1, 2020
The Dysregulation of OGT/OGA Cycle Mediates Tau and APP Neuropathology in Down SyndromeIlaria Zuliani, Chiara Lanzillotta, Antonella Tramutola, et al.Diabetes/Metabolism Research and Reviews|May 1, 2009
Advanced glycation end products in diabetic patients with optimized glycaemic control and their effects on endothelial reactivity: possible implications in venous graft failureMassimo Chello, Cristiano Spadaccio, Mario Lusini, et al.Journal of Proteome Research|December 17, 2008
Proteomics-determined differences in the concanavalin-A-fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimer's disease and mild cognitive impairment: implications for progression of ADJoshua B Owen, Fabio Di Domenico, Rukhsana Sultana, et al.Journal of Alzheimer'S Disease : JAD|February 15, 2018
Early and Selective Activation and Subsequent Alterations to the Unfolded Protein Response in Down Syndrome Mouse ModelsChiara Lanzillotta, Antonella Tramutola, Shelby Meier, et al.Research in Cardiovascular Medicine|September 23, 2015
Pharmacologic Approaches Against Advanced Glycation End Products (AGEs) in Diabetic Cardiovascular DiseaseAntonio Nenna, Francesco Nappi, Sanjeet Singh Avtaar Singh, et al.Brain Research|April 6, 2010
Protein levels of heat shock proteins 27, 32, 60, 70, 90 and thioredoxin-1 in amnestic mild cognitive impairment: an investigation on the role of cellular stress response in the progression of Alzheimer diseaseFabio Di Domenico, Rukhsana Sultana, Georgianne F Tiu, et al.Biochimica Et Biophysica Acta. Molecular Basis of Disease|July 9, 2018
Biliverdin reductase-A impairment links brain insulin resistance with increased Aβ production in an animal model of aging: Implications for Alzheimer diseaseFrancesca Triani, Antonella Tramutola, Fabio Di Domenico, et al.Journal of Alzheimer'S Disease : JAD|July 11, 2012
HO-1/BVR-a system analysis in plasma from probable Alzheimer's disease and mild cognitive impairment subjects: a potential biochemical marker for the prediction of the diseaseFabio Di Domenico, Eugenio Barone, Cesare Mancuso, et al.Pageof 11